StemCell Institute Inc 7096.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 05/10/24 JST
1,910.00quote price arrow up+36.00 (+1.92%)
Volume
13,700
52 week range
1,728.00 - 3,285.00
Loading...
  • Open1,877.00
  • Day High1,910.00
  • Day Low1,847.00
  • Prev Close1,874.00
  • 52 Week High3,285.00
  • 52 Week High Date07/04/23
  • 52 Week Low1,728.00
  • 52 Week Low Date03/18/24

Key Stats

  • Market Cap127.31M
  • Shares Out10.25M
  • 10 Day Average Volume10,110
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-10.91

KEY STATS

  • Open1,877.00
  • Day High1,910.00
  • Day Low1,847.00
  • Prev Close1,874.00
  • 52 Week High3,285.00
  • 52 Week High Date07/04/23
  • 52 Week Low1,728.00
  • 52 Week Low Date03/18/24
  • Market Cap127.31M
  • Shares Out10.25M
  • 10 Day Average Volume10,110
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-10.91

RATIOS/PROFITABILITY

  • EPS (TTM)34.20
  • P/E (TTM)55.85
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On StemCell Institute Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
StemCell Institute Inc is mainly engaged in the cell bank business, which separates and stores cord blood. The Company operates cell bank business from umbilical cord blood and umbilical cord, development of new treatment methods and regenerative medicine products, regenerative medicine and fertility treatment, business development and investment in childbirth and childcare areas. The Company operates Cell Bank business segment. After signing the contract for the separation...
Takafumi Shimizu
President, Representative Director
Address
Matsuoka Tamuracho Bldg.
5-22-10, Shimbashi
Minato-ku, TKY
105-0001
Japan